These findings extend our prior work demonstrating MDC depletion as a hallmark of COVID-19 convalescence (both acute and 3 months post-infection) and may suggest new immunological characteristics in the post-pandemic population [37]. The gene discussed is CCL22; the disease is COVID-19.